Type 2 Diabetes
2,564
265
356
1,568
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
368 trials with published results (14%)
Research Maturity
1568 completed trials (61% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.4%
113 terminated out of 2564 trials
93.3%
+6.7% vs benchmark
20%
518 trials in Phase 3/4
23%
368 of 1568 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1568 completed trials
Clinical Trials (2564)
Remotely Delivered Mindfulness-Based Diabetes Education
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication
Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
The Genomic Medicine at VA Study
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
The PRECISION-T2D Study: Precision Nutrition Study for Type 2 Diabetes
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes
Changing Health Through Food Support for Diabetes
Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus
A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects
The LifeMeds Cohort
PROTeIn-rich Meals to Control Glucose
Effects of Antipsychotics on Brain Insulin Action in Females
A Study of HRS-4729 Injection in Participants With Type 2 Diabetes
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes